Elizabeth McCall

Title: Elizabeth McCall: Innovator in Pharmaceutical Compositions

Introduction

Elizabeth McCall is a prominent inventor based in Dalkeith, Australia. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory disorders. With a total of five patents to her name, her work has the potential to impact many lives.

Latest Patents

One of Elizabeth's latest patents focuses on a method for treating inflammatory disorders. This invention relates to pharmaceutical compositions that include at least one angiotensin receptor blocker or a pharmaceutically acceptable salt thereof, along with at least one chemokine receptor pathway inhibitor or a pharmaceutically acceptable salt thereof. The invention also encompasses oral sustained release pharmaceutical compositions and injectable sustained release formulations. Additionally, it describes various dosage forms such as tablets, capsules, and compositions for pulmonary or nasal delivery. Methods for assessing the efficacy and inhibition activity of the pharmaceutical composition are also included, along with methods for treating, ameliorating, or preventing conditions or diseases.

Career Highlights

Elizabeth McCall is currently associated with Dimerix Bioscience Pty Ltd., where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to developing effective treatments for complex health issues.

Collaborations

Some of her notable coworkers include Kevin D G Pfleger and James Williams, who contribute to her research and development efforts.

Conclusion

Elizabeth McCall stands out as a dedicated inventor in the pharmaceutical industry, with her innovative approaches to treating inflammatory disorders. Her contributions are paving the way for advancements in medical treatments.